Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey L Anderson

Showing results (1-10 of 395) with videos related to

Pageof 40
Sort By:
Journal of Cardiovascular Electrophysiology|October 13, 2006
Dual-chamber pacemakers as long-term telemetry devices: ready for prime-time in diagnosing unsuspected atrial fibrillation?Jeffrey L Anderson
Circulation|April 15, 2009
Stopping the hemorrhage: a new baseline bleeding score brings us a step closer for patients with non-ST-elevation myocardial infarctionJeffrey L Anderson
The New England Journal of Medicine|April 22, 2005
Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?Jeffrey L Anderson
Circulation Research|December 9, 2017
Circulating Thyroxine: A Major New Risk Marker for Atherosclerosis?Jeffrey L Anderson
The American Journal of Cardiology|April 22, 2024
Longer-Duration Dual Antiplatelet Therapy in Medically-Treated Patients after Myocardial Infarction: What is the Strength of the Evidence?Jeffrey L Anderson
Circulation. Population Health and Outcomes|February 13, 2026
Cracks in the Great Wall: Acute MI Beyond Traditional Risks in Chinese PatientsJeffrey L Anderson
Journal of the American College of Cardiology|June 27, 2015
Evolution of the ACC/AHA Clinical Practice Guidelines in Perspective: Guiding the GuidelinesJeffrey L Anderson
European Heart Journal|October 12, 2017
Improving secondary cardiovascular risk prediction: taking a few steps along the long path from probability toward certaintyJeffrey L Anderson
The American Journal of Cardiology|July 25, 2008
Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary preventionJeffrey L Anderson
European Heart Journal. Quality of Care & Clinical Outcomes|May 19, 2020
Making better use of appropriate use criteriaJeffrey L Anderson
Pageof 40

Showing results (1-10 of 395) with videos related to

Sort By:
Pageof 40
Journal of Cardiovascular Electrophysiology|October 13, 2006
Dual-chamber pacemakers as long-term telemetry devices: ready for prime-time in diagnosing unsuspected atrial fibrillation?Jeffrey L Anderson
Circulation|April 15, 2009
Stopping the hemorrhage: a new baseline bleeding score brings us a step closer for patients with non-ST-elevation myocardial infarctionJeffrey L Anderson
The New England Journal of Medicine|April 22, 2005
Infection, antibiotics, and atherothrombosis--end of the road or new beginnings?Jeffrey L Anderson
Circulation Research|December 9, 2017
Circulating Thyroxine: A Major New Risk Marker for Atherosclerosis?Jeffrey L Anderson
The American Journal of Cardiology|April 22, 2024
Longer-Duration Dual Antiplatelet Therapy in Medically-Treated Patients after Myocardial Infarction: What is the Strength of the Evidence?Jeffrey L Anderson
Circulation. Population Health and Outcomes|February 13, 2026
Cracks in the Great Wall: Acute MI Beyond Traditional Risks in Chinese PatientsJeffrey L Anderson
Journal of the American College of Cardiology|June 27, 2015
Evolution of the ACC/AHA Clinical Practice Guidelines in Perspective: Guiding the GuidelinesJeffrey L Anderson
European Heart Journal|October 12, 2017
Improving secondary cardiovascular risk prediction: taking a few steps along the long path from probability toward certaintyJeffrey L Anderson
The American Journal of Cardiology|July 25, 2008
Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary preventionJeffrey L Anderson
European Heart Journal. Quality of Care & Clinical Outcomes|May 19, 2020
Making better use of appropriate use criteriaJeffrey L Anderson
Pageof 40